St. Albans, VT, United States of America

Kenneth James Miller, Ii

This inventor holds 10 USPTO granted patents. Top assignees: Mylan Technologies, Inc., Mylan Pharmaceuticals Inc.. Active years: 2009-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth James Miller, Ii. Retrieved from https://idiyas.com/inventor/kenneth-james-miller-ii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 70.0

Average Co-Inventor Count = 1.7

ph-index = 7

Forward Citations = 93(Granted Patents)


Company Filing History:


Years Active: 2009-2016

Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Mind of Kenneth James Miller, II

Introduction

Kenneth James Miller, II, an accomplished inventor based in St. Albans, Vermont, has made significant contributions to the field of transdermal drug delivery systems. With an impressive portfolio of ten patents, he is well-regarded for his innovative approaches to modifying drug delivery mechanisms.

Latest Patents

Among his latest patents is a pioneering invention for transdermal systems containing multilayer adhesive matrices that modify drug delivery. This invention consists of a drug-containing dosage unit featuring a backing layer that prevents the drug from escaping and two polymeric adhesive matrices, each with distinct drug delivery profiles. This design allows for controlled and selective modification of the drug delivery through the skin.

In addition, Miller has developed a transdermal patch that incorporates an active agent migration barrier layer. This double-disk patch design features an outer layer that serves as an adhesive and an inner layer containing the active agent for administration. The innovative use of a release layer inhibits the unwanted migration of the active agent, ensuring precise delivery to the host.

Career Highlights

Throughout his career, Kenneth has collaborated with notable organizations, such as Mylan Technologies, Inc. and Mylan Pharmaceuticals Inc. His work focuses on improving drug delivery systems, demonstrating a commitment to advancing healthcare technology.

Collaborations

Miller's success is also attributed to his collaborations with skilled professionals like Kristin Jackson and Sharad K Govil. Working alongside these talented individuals has undoubtedly contributed to the development of his pioneering inventions and the expansion of his patent portfolio.

Conclusion

Kenneth James Miller, II's inventive spirit and contributions to transdermal drug delivery systems have had a lasting impact on the pharmaceutical industry. With each patent, he continues to push the boundaries of innovation, ensuring that drug delivery methods remain effective and efficient. As a leading figure in his field, he exemplifies the role of an innovator dedicated to improving health outcomes for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…